[Clinical studies on cefteram pivoxil in pediatrics].
Cefteram pivoxil (CFTM-PI), a newly developed oral cephem antibiotic was administered to treat 16 children with various infections. The results were summarized as follows. 1. The clinical responses were "excellent" in 7, "good" in 5, "fair" in 3 and "poor" in 1, with 75.0% efficacy rate. 2. No side effects and no abnormal laboratory findings were observed.
Yokoyama
M
M
Department of Pediatrics, School of Medicine, Hirosaki University.
Yonesaka
S
S
Aoyama
R
R
Sudou
Y
Y
D001424:Bacterial Infections / Q000188:drug therapy*; D015281:Cefmenoxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male
C046817:cefteram pivoxil; D015281:Cefmenoxime